期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌EGFR突变的检测方法 被引量：3

The Detection Methods of EGFR Mutations in Non-small Cell Lung Cancer
下载PDF
导出
摘要 非小细胞肺癌（non-small cell lung cancer,NSCLC）是严重危害人类健康的常见恶性肿瘤。近年来表皮生长因子受体酪氨酸激酶抑制剂（epidermal growth factor receptortyrosine kinase inhibitor,EGFR-TKI）为NSCLC的治疗带来新的曙光,但用药前必须依据表皮生长因子受体（epidermalgrowth factor receptor,EGFR）的突变检测结果选择治疗对象。
作者 张鑫宇 刘皈阳 祝晓光 王伟兰
机构地区 蚌埠医学院药学系 解放军总医院第一附属医院药剂药理科 解放军总医院药品保障中心
出处 《中国肺癌杂志》 CAS 2011年第3期297-302,共6页 Chinese Journal of Lung Cancer
关键词 非小细胞肺癌 检测结果 EGFR 突变 表皮生长因子受体 受体酪氨酸激酶抑制剂 RECEPTOR NSCLC
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献39

  • 1Lynch T, Bell D, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N EnglJ Med, 2004, 350(21): 2129-2139.
  • 2Paez J, Janne P, Lee J, et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science, 2004, 304(4): 1497-1500.
  • 3Pao W, Miller Vj Zakowski M, et al. EGF receptor gene mutations are common in lung can-cers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. PNAS, 2004. 101(36): 13306-13311.
  • 4Sae WH, Tae YK, Pil GH, et al. Predictive and prognostic impact of epidermal growthfactor receptor mutation in non-smallcell lung cancer Patients treated with Gefitinib. J Clin Oncol, 2005, 23 (11): 2493-2501.
  • 5Taron M, Ichinose Z Rosell Rj et aL Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas. Clin Cancer Res, 2005, 11 (16): 5878-5885.
  • 6Guo J, Zhou SW, Zhang L, et al. Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of geftinib treatment in advanced non-small cell lung cancer. J Cancer Res Clin Oncol, 2010, 136(9): 1341-1347.
  • 7Rafael R, Teresa M, Cristina Q et al. Screening for epidermal growth factor receptor mutations in lung cancer. N EnglJ Med, 2009, 360(10): 958-968.
  • 8周彩存,周崧雯,潘虹,粟波,高志强.TaqMan—MGB探针实时荧光聚合酶链反应快速检测非小细胞肺癌表皮生长因子受体基因突变[J].中华肿瘤杂志,2007,29(2):119-123. 被引量：11
  • 9李永文,刘红雨,李颖,王玉丽,王竞,陈军,周清华.实时荧光定量PCR和测序法检测非小细胞肺癌EGFR基因突变的比较[J].中国肺癌杂志,2009,12(12):1255-1259. 被引量：11
  • 10白桦,赵军,王书航,安彤同,王鑫,吴梅娜,段建春,杨鹭,郭庆志,刘宁红,王洁.变性高效液相色谱法检测非小细胞肺癌患者外周血及肿瘤组织表皮生长因子受体突变[J].中华结核和呼吸杂志,2008,31(12):891-896. 被引量：17

二级参考文献93

共引文献71

同被引文献45

  • 1赵实诚,许洋.蛋白指纹技术在临床医学的应用与研究进展[J].中华检验医学杂志,2004,27(10):706-709. 被引量：16
  • 2Su KY,Chen HY,Li KC,et al.Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer[J].J Clin Oncol,2012,30(4):433-440.
  • 3Costa DB,Kobayashi S,Tenen DG,et al.Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers[J].Lung Cancer,2007,58(1):95-103.
  • 4Kosaka T,Yatabe Y,Endoh H,et al.Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib[J].Clin Cancer Res,2006,12(19):5764-5769.
  • 5Brevet M,Johnson ML,Azzoli CG,et al.Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors[J].Lung Cancer,2011,73 (1):96-102.
  • 6Bai H,Mao L,Wang HS,et al.Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages ⅢB to Ⅳ non-small-cell lung cancer[J].J Clin Oncol,2009,27 (16):2653-2659.
  • 7秦楚,王朝霞.非小细胞肺癌个体化治疗研究进展[J].中华临床医师杂志(电子版),2013,7(21):9681-9686.
  • 8Wu X,Liang W,Hou X,et al.Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC[J].Onco Targets Ther,2013,6:1481-1491.
  • 9Yanagisawa K,Shyr Y,Xu BJ,et al.Proteomic patterns of tumor subsets in non-small cell lung cancer[J].Lancet,2003,362 (9382):433-439.
  • 10Lazzari C,Spreafico A,Bachi A,et al.Changes in plasma massspectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors[J].J Thorac Oncol,2012,7(1):40-48.

引证文献3

二级引证文献14

中国肺癌杂志
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部